Velico Medical, Inc. is a private, pre-clinical, US medical technology company headquartered in Beverly, Massachusetts.
The Velico team is committed to the mission of stopping preventable death from bleeding. Uncontrolled bleeding is the number one cause of preventable death following trauma globally. We will accomplish our mission by equipping regional blood centers around the world to respond to the urgent clinicians need for a locally produced, point of injury, dry plasma product for transfusion. We will partner and be guided by civilian, government and military blood center staff, trauma surgeons, emergency medical physcians, military medics and first responders worldwide.
Velico is developing a breakthrough, platform technology for manufacturing spray dried human plasma.. The FrontlineODP™ system will be deployed at regional blood centers who will produce dry plasma (versus freezing it, the current standard) for use by hospitals, emergency first responders and the military. Dry plasma is a logistically superior product which extends the availability of plasma from the hospital to the point of injury, including rural and austere settings.
Velico’s business model is based on partnerships with regional blood centers which collect, test and manufacture life saving blood components everyday. Velico’s FrontlineODP™ system has been designed for straight forward integration into existing blood component manufacturing centers without the need for specialized processing environments (e.g.clean rooms).
The FrontlineODP™ development program is funded by the Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services under contract HHS0100201200005C . Velico is grateful for its partnership with BARDA without whom the development of this life saving technology would not be possible.